Month: July 2021

TORONTO, July 23, 2021 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that its board of directors (the “Board”) has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on August 13, 2021 to holders of Common Shares of record on July 30, 2021. The Company also offers a Dividend Reinvestment Plan (the “Plan”), which is eligible to holders of Common Shares and provides a convenient means to purchase additional Common Shares by reinvesting cash dividends at a potential discount and without having to pay commissions, service charges or brokerage fees. Pursuant to the Plan and at the discretion of Timbercreek Capital Inc., the Manager, Common Shares will be acquired in the open market at prevailing prices or issued from treasury at 98 percent...

RALLY Study Will Stop Enrolling New Participants Following Recommendation from an Interim Analysis Indicating Inadequate Separation from Placebo at Week-14 in the First 50% of Participants, Based on the Original Targeted Study Size Company Plans to Unblind and Report Topline Results in the Fourth Quarter of 2021 Following Completion of Study for Currently Enrolled Participants RALLY Study Follows Announcement in December 2020 of Positive Results from First Phase 3 Study, RELIEF, of TNX-102 SL 5.6 mg for the Management of Fibromyalgia CHATHAM, N.J., July 23, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that the Company has decided to stop enrollment in the Phase 3 RALLY study of TNX-102 SL (cyclobenzaprine HCl sublingual...

EDISON, N.J., July 23, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”), today announced the postponement of its adjourned 2021 Annual Meeting of Stockholders (the “Annual Meeting”) that was to be held on July 23, 2021, at 9:00 a.m. Eastern Time due to a lack of a quorum. The meeting will be rescheduled for a date yet to be determined by the Board of Directors. The Board of Directors will establish a new record date for the Annual Meeting and, based on this record date, the Company will deliver a notice of the new Annual Meeting date to stockholders entitled to receive notice of the Annual Meeting. About Hepion...

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (the “Company” and together with its consolidated subsidiaries, “Apollo”) announced today that its 2021 Annual Meeting of Stockholders (“Annual Meeting”) will be held on October 1, 2021, at 9:30 a.m., Eastern Daylight Time. The record date for the meeting is August 5, 2021. The Annual Meeting will be held virtually as a result of continuing concerns surrounding the COVID-19 pandemic. Proxy materials will be mailed to stockholders of record on or about August 16, 2021, and will be available on the Securities and Exchange Commission’s website at www.sec.gov and on the Company’s website at www.apollo.com. About Apollo Apollo is a high-growth, global alternative asset manager. We seek to provide our clients excess return at every point...

STEINHAUSEN, Switzerland, July 23, 2021 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the second quarter of 2021 after markets close on Monday, August 2, 2021. The company will conduct a teleconference to discuss the results starting at 9 a.m. EDT, 3 p.m. CEST, on Tuesday, August 3, 2021. Individuals who wish to participate should dial +1 313-209-6544 and refer to conference code 1865445 approximately 10 minutes prior to the scheduled start time. The teleconference will be simulcast in a listen-only mode at: www.deepwater.com, by selecting Investors, News, and Webcasts. A replay of the conference call will be available after 12 p.m. EDT, 6 p.m. CEST, on August 3, 2021. The replay, which will be archived for approximately 30 days, can be accessed at +1 719-457-0820, passcode 1865445,...

EMLENTON, Pa., July 23, 2021 (GLOBE NEWSWIRE) — Emclaire Financial Corp (NASDAQ:EMCF), the parent holding company of The Farmers National Bank of Emlenton, reported consolidated net income available to common stockholders of $1.8 million, or $0.67 per diluted common share, for the three months ended June 30, 2021, an increase of $636,000, or 52.9%, from $1.2 million, or $0.44 per diluted common share, reported for the comparable period in 2020.  Net income available to common shareholders for the six-month period ended June 30, 2021 was $4.0 million, or $1.46 per diluted common share, an increase of $1.6 million, or 67.7%, from $2.4 million, or $0.88 per diluted common share, for the same period in 2020.  The increase in net income for both periods compared to the same periods in 2020 resulted from an increase in net interest income...

CLEVELAND, July 23, 2021 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (Nasdaq: LECO) today announced participation in the following upcoming events with the financial community in the month of August: Jefferies Virtual Industrials Conference Wednesday, August 4, 2021 8:30 a.m. Eastern Time Gabriel Bruno, Executive Vice President and Chief Financial Officer The Jefferies Virtual Industrials Conference presentation will be webcast and can be accessed on our Investor Relations web site at https://ir.lincolnelectric.com. A replay will also be available on our web site. Northcoast Research 2021 Industrial and Business Services Conference Monday, August, 9, 2021 Gabriel Bruno, Executive Vice President and Chief Financial Officer Seaport Global Annual Virtual Summer Investor Conference Wednesday, August 25, 2021 Gabriel...

BROOKLYN, N.Y., July 23, 2021 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announced that on July 15, 2021, Jay Sial was granted a non-qualified stock option covering 71,000 shares of Brooklyn’s common stock (the “Time-Based Option”) and a restricted stock unit covering 35,700 shares of Brooklyn’s common stock (the “RSU”). The RSU will vest in four equal installments, with one-fourth of the shares covered by such RSU vesting on the anniversary of the grant date in each of 2022, 2023, 2024 and 2025, in each case for so long as Mr. Sial provides continuous service to Brooklyn through the relevant vesting...

CAMBRIDGE, Mass., July 23, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced it will share multiple oral and poster presentations from its Alzheimer’s disease clinical development portfolio at the Alzheimer’s Association International Conference (AAIC), which will be held in Denver, Colorado and online July 26-30, 2021. The company’s contributions to AAIC will include several presentations highlighting data on ADUHELM™ (aducanumab-avwa) injection 100 mg/mL solution, which was recently granted accelerated approval by the U.S. Food and Drug Administration (FDA) as a treatment for Alzheimer’s disease, as well as its broader Alzheimer’s disease portfolio and research in the field. ADUHELM is indicated for the treatment of Alzheimer’s disease. Treatment with ADUHELM should be initiated in patients with mild cognitive...

PHILADELPHIA, July 23, 2021 (GLOBE NEWSWIRE) — Prudential Bancorp, Inc. (the “Company”) (Nasdaq:PBIP), the holding company for Prudential Bank (the “Bank”), reported net income of $2.2 million, or $0.28 per basic and per diluted share, for the quarter ended June 30, 2021 as compared to $3.6 million, or $0.44 per basic and per diluted share, for the same quarter in fiscal 2020. For the nine months ended June 30, 2021, the Company reported net income of $5.8 million, or $0.73 per basic share and $0.72 per diluted share as compared to $9.0 million, or $1.04 per basic and $1.03 per diluted share, for the same period in fiscal 2020.   The 2020 periods included significant gains on sales of investment securities available for sale. Dennis Pollack, President and CEO, commented, “We are pleased to report continued positive operating results....